Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT01363193
Eligibility Criteria:
Inclusion Criteria:
* Patients with body mass index greater than or equal to 30
* Patients admitted to Nazareth Hospital inpatient units
* Weight-based intravenous heparin, with a diagnosis of atrial fibrillation, suspected or confirmed deep vein thrombosis or pulmonary embolism, unstable angina or Non ST elevation myocardial infarction with hemodynamic stability, or peripheral vascular disease, ordered at the time of admission/transfer or during the patient stay in the Intensive Care unit or Progressive Care unit.
* Prior permission from the patient's attending physician
* Permission from the physician who ordered the intravenous weight-based heparin (if different from the attending)
* Signed consent form by the patient.
Exclusion Criteria:
* Patients with stroke, TIA, or ST elevation myocardial infarction
* Patients who have hemodynamic or cardiopulmonary instability at the time of intravenous heparin order
* Patients with thrombophilia
* Patients who are pregnant or may be pregnant
* Those patients who have been on any oral anticoagulants (Warfarin, rivaroxaban, dabigatran or apixaban), treatment dose of other anticoagulants or intravenous thrombolytics in previous 7 days.
* Patients who have a PTT greater than 37 seconds.
* History of heparin-induced thrombocytopenia or known allergy to heparin
* Deviation from the Weight-based heparin protocol ordered by a physician at the time intravenous heparin was written (i.e. no bolus dose ordered, different target therapeutic aPTT range, different bolus dose per kg, etc.)
* Informed consent either refused or not obtained
* Objection from a physician caring for the patient
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01363193
Study Brief:
Protocol Section:
NCT01363193